Ken Herrmann

34.7k citations
590 papers · 19.7k · 10 hit papers · h-index 72

Impact in

Papers in

Ken Herrmann

566 papers receiving 19.5k citations

Ken Herrmann's Hit Papers

[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study 2024 · 145 citations
1450+6+12Years since publication50010001.5k

Peers

Ken Herrmann
Comparison fields: 5 of 144
  • Radiology, Nuclear Medicine and Imaging 8.0k
  • Pulmonary and Respiratory Medicine 8.5k
  • Oncology 4.5k
  • Cancer Research 1.4k
  • Neurology 897
Replace Stefano Fanti with:
Stefano Fanti Italy
Barry A. Siegel United States
Otto S. Hoekstra Netherlands
Rodney J. Hicks Australia
Heiko Schöder United States
Uwe Haberkorn Germany
Johannes Czernin United States
Gerald Antoch Germany
Domenico Rubello Italy
Riad Salem United States
Ken Herrmann relative to Stefano Fanti Italy Stefano Fanti's profile →
Citations per field
00.5×3.5×
Stefano Fanti · 1×
Citations per year

Countries citing papers authored by Ken Herrmann

Since Specialization
Citations

This map shows the geographic impact of Ken Herrmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Herrmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Herrmann more than expected).

Fields of papers citing papers by Ken Herrmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Herrmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Herrmann. The network helps show where Ken Herrmann may publish in the future.

Co-authors

The 25 scholars most cited alongside Ken Herrmann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ken Herrmann Line = papers co-authored together Ken Herrmann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 590 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Hit paper breakdown →
20211582
2
68Ga-PSMA PET/CT: Joint EANM and SNMMI procedure guideline for prostate cancer imaging: version 1.0
Hit paper breakdown →
2017574
3
PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial
Hit paper breakdown →
2007553
4
Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE): Proposed miTNM Classification for the Interpretation of PSMA-Ligand PET/CT
Hit paper breakdown →
2017406
5 2006346
6 2007291
7
Radiotheranostics in oncology: current challenges and emerging opportunities
Hit paper breakdown →
2022243
8 2017226
9
E-PSMA: the EANM standardized reporting guidelines v1.0 for PSMA-PET
Hit paper breakdown →
2021225
10 2017202
11 2015194
12 2019188
13 2020187
14 2017183
15 2017166
16 2015164
17 2015163
18 2016159
19 2016155
20 2017153

About Ken Herrmann

Ken Herrmann is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Surgery, having authored 590 papers that have together received 19.7k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (133 papers), Radiopharmaceutical Chemistry and Applications (130 papers), Medical Imaging Techniques and Applications (117 papers), Radiomics and Machine Learning in Medical Imaging (61 papers), Neuroendocrine Tumor Research Advances (59 papers), Peptidase Inhibition and Analysis (44 papers), Lung Cancer Research Studies (36 papers) and Prostate Cancer Diagnosis and Treatment (36 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (8.0k citations), Pulmonary and Respiratory Medicine (8.5k citations), Oncology (4.5k citations), Cancer Research (1.4k citations) and Neurology (897 citations). Ken Herrmann has collaborated with scholars based in Germany, United States and Italy. Frequent co-authors include Wolfgang P. Fendler, Andreas K. Buck, Markus Schwaiger, Bernd J. Krause, Johannes Czernin, Constantin Lapa, Matthias Eiber, Wolfgang Weber, Boris Hadaschik and Hans‐Jürgen Wester. Their work appears in journals such as Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, Journal of Clinical Oncology, Nuklearmedizin - NuclearMedicine and Seminars in Nuclear Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact